| Literature DB >> 26468650 |
Yanping Zhao1, Tongyong Luo2, Joseph D Tucker3, William Chi Wai Wong1.
Abstract
BACKGROUND: Sexually Transmitted Infections (STIs) are a global challenge. China, once said to have eradicated STIs, is now facing a rapid rise in the prevalence of HIV/STIs. This review of reviews aims to map HIV/STI risk factors among the Chinese population, with the objective of identifying risk factors to inform the formulation of effective prevention strategies.Entities:
Mesh:
Year: 2015 PMID: 26468650 PMCID: PMC4607362 DOI: 10.1371/journal.pone.0140426
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Quality assessment of included studies using the Assessment of Multiple Systematic Reviews (AMSTAR).
| Study | SR/M | A1 | A2 | A3 | A4 | A5 | A6 | A7 | A8 | A9 | A10 | A11 | AMSTAR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chow et al. (2011) | M | 0 | 1 | 1 | 0 | 0.5 | 1 | 1 | 0.5 | 1 | 1 | 0.5 |
|
| Li et al. (2011) | M | 0 | 1 | 1 | 0 | 0.5 | 1 | 1 | 0.5 | 1 | 1 | 0.5 |
|
| He et al. (2011) | SR | 0 | 1 | 1 | 1 | 0.5 | 1 | 0 | 0 | 1 | 1 | 0.5 |
|
| Guo et al. (2011) | SR | 0 | 0 | 1 | 0 | 0.5 | 1 | 0 | 0 | 1 | 0 | 0.5 |
|
| Gao et al. (2009) | M | 0 | 0 | 1 | 0 | 0.5 | 1 | 1 | 0 | 1 | 1 | 0 |
|
| Yun et al. (2011) | M | 0 | 1 | 1 | 0 | 0.5 | 1 | 1 | 1 | 1 | 1 | 0.5 |
|
| Meng et al. (2013) | M | 0 | 0.5 | 1 | 0 | 0.5 | 1 | 0 | 0 | 1 | 1 | 0.5 |
|
| Chow et al. (2011) | M | 0 | 0.5 | 1 | 0 | 0.5 | 1 | 1 | 0 | 1 | 1 | 0.5 |
|
| Qiu et al. (2013) | M | 0 | 0 | 1 | 1 | 0.5 | 0.5 | 0 | 0 | 1 | 1 | 0 |
|
| Chow et al. (2012) | M | 0 | 0.5 | 1 | 0 | 0.5 | 1 | 1 | 0 | 1 | 1 | 1 |
|
| Zhuang et al. (2012) | M | 0 | 1 | 1 | 0 | 0.5 | 1 | 1 | 1 | 1 | 1 | 1 |
|
| Chow et al. (2011) | M | 0 | 1 | 1 | 1 | 0.5 | 1 | 0 | 0 | 1 | 1 | 1 |
|
| Zhuang et al. (2012) | M | 0 | 1 | 0 | 0 | 0.5 | 1 | 1 | 1 | 1 | 1 | 1 |
|
| Bao et al. (2009) | SR | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
|
| Wang et al. (2010) | M | 0 | 0 | 0.5 | 0 | 0.5 | NA | 0 | 0 | 1 | 0 | 0 |
|
| Xing et al. (2013) | M | 0 | 0 | 0.5 | 0 | 0.5 | NA | 1 | 1 | 1 | 1 | 0 |
|
| Hong et al. (2008) | M | 0 | 0 | 0.5 | 0 | 0.5 | 1 | 0 | 0 | NA | 0 | 1 |
|
| Yang et al. (2013) | M | 0 | 1 | 0.5 | 0 | 0.5 | 1 | 0.5 | 0 | 1 | 0 | 1 |
|
| Poon et al. (2011) | SR | 0 | 0 | 0.5 | 0 | 0.5 | 1 | 0 | 0 | NA | 0 | 1 |
|
| Liu et al. (2012) | M | 0 | 0 | 0.5 | 0 | 0.5 | 1 | 0 | 0 | 1 | 1 | 1 |
|
| Zhang et al. (2013) | M | 0 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 0 | 1 | 1 | 1 |
|
| Zhang et al. (2013) | M | 0 | 1 | 0.5 | 0 | 0.5 | 1 | 1 | 0 | 1 | 1 | 1 |
|
| Zhang et al. (2013) | SR | 0 | 1 | 1 | 1 | 0.5 | 1 | 0 | 0 | 1 | 0 | 1 |
|
| Li et al. (2010) | SR | 0 | 0 | 0.5 | 0 | 0.5 | 1 | 0 | 0 | 1 | 0 | 1 |
|
| Lin et al. (2006) | SR | 0 | 0 | 0.5 | 0 | 0.5 | 0 | 0 | 0 | NA | 0 | 1 |
|
| Yang et al. (2005) | SR | 0 | 0 | 1 | 1 | 0.5 | 1 | 0 | 0 | 1 | 0 | 0 |
|
| Hong et al. (2012) | M | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
|
| Zang et al. (2011) | M | 0 | 1 | 1 | 1 | 0.5 | 1 | 0 | 0 | 1 | 0 | 1 |
|
| Mean |
| ||||||||||||
| Standard Deviation |
|
(SR) Systematic review; (M) Meta-analysis; (A1…A11) AMSTAR Items (please find in the AMSTAR Checklist in the S3 Appendix), scored as 0 or 1; (AMSTAR) AMSTAR Score ranging from 0–11; (NA) Not Applicable
Provinces/regions with the highest HIV prevalence amongst key populations in China.
| Type of population Year | Provinces/regions with the highest prevalence | Pooled HIV prevalence | |||||
|---|---|---|---|---|---|---|---|
| Blood donors 2010 [ | Yunnan (125.97⁄100,000) Southwest | Guangxi (32.40⁄100,000) South | Guizhou (19.60⁄100,000) Southwest | Xinjiang (44.09⁄100,000) Northwest | Chongqing (18.22⁄100,000) Southwest | Tibet (24.02⁄100,000) Southwest | 13.22⁄100,000 (12.10–4.40) (2000–2009) |
| FSW 2000–2011 [ | Yunnan 4·79% (95%CI 3.35–6.24%) Southwest | Chongqing (0.98%; 95%CI 0.04–1.93%) Southwest | Guangxi (0.45%; 95%CI 0.31–0.59%) South | Sichuan (0.43%; 95%CI 0.20–0.66%) Southwest | Xinjiang (0·36%; 95%CI 0.18–0.54%) Northwest | Zhejiang (0.22%; 95%CI 0.10–0.34%) East Hainan (0.22%; 95%CI 0.06–0.37%) South | 0.20% (95%CI 0.172–0.233%) (2000–2011) |
| MSM [ | 8.2% (95%CI 3.8–12.6%) in 2006 to 11.4% (95%CI 9.2–13.6%) in 2009 Southwest | 3.9% (95%CI 0.2–7.5%) in 2006 to 8.6% (95%CI 7.1–10.1%) in 2009 Northeast | 0.8% (95%CI 0.0–1.8%) in 2006 to 6.5% (95%CI 3.1–9.9%) in 2009 Northwest | 1.2% (95%CI 0.2–2.3%) in 2004 to 5.4% (95%CI 3.3–7.5%) in 2009 South central | 0.7% (95%CI 0.0–2.1%) in 2003 to 5.5% (95%CI 2.6–8.4%) in 2009 East | 1.7% (95%CI 0.0–3.9%) in 2003 to 4.8% (95%CI 2.5–7.0%) in 2009 North | 4.3% (95%CI 3.7–4.9%) (2003–2009) 0.6% (95%CI 0.0–2.1%) (2003) to 7.4% (95%CI 5.7–9.2%) (2009) |
| Drug users 1993–2009 [ | 12.9% (95%CI 7.7–18.2%) North | 8.6% (95%CI 6.1–11.1%), Southwest | 7.4% (95%CI 0.7–14.195%CI) Mid-China | 3.0% (95%CI 2.3–3.6%) South | 1.0% (95%CI 0.6–1.4%) East | 0.9% (95%CI 0.2–1.7%) Northwest | 3.3% (95%CI 2.9–3.7%) |
| PWID 2010 [ | 14·61% (95%CI 10.53–20.46%) Southwest | 13.56% (95%CI 9.47–18.82%) Northwest | 6·29% (95%CI 5.17–7.99%) South central | 9.08% (95%CI 8.04–10.52%) | |||